| Dopamine and glutamate in antipsychotic-responsive compared with antipsychotic-nonresponsive psychosis: a multicenter positron emission tomography and magnetic resonance … A Egerton, A Murphy, J Donocik, A Anton, GJ Barker, T Collier, B Deakin, ... Schizophrenia bulletin 47 (2), 505-516, 2021 | 67 | 2021 |
| Demographic and clinical variables associated with response to clozapine in schizophrenia: a systematic review and meta-analysis K Griffiths, E Millgate, A Egerton, JH MacCabe Psychological Medicine 51 (3), 376-386, 2021 | 26 | 2021 |
| Clozapine response in schizophrenia and hematological changes G Blackman, JEL Lisshammar, R Zafar, TA Pollak, M Pritchard, AE Cullen, ... Journal of clinical psychopharmacology 41 (1), 19-24, 2021 | 20 | 2021 |
| Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration A Egerton, K Griffiths, C Casetta, B Deakin, R Drake, OD Howes, ... Neuropsychopharmacology 48 (3), 567-575, 2023 | 14 | 2023 |
| Early trajectory of clinical global impression as a transdiagnostic predictor of psychiatric hospitalisation: a retrospective cohort study M Taquet, K Griffiths, EOC Palmer, S Ker, C Liman, SN Wee, SH Kollins, ... The Lancet Psychiatry 10 (5), 334-341, 2023 | 9 | 2023 |
| A polygenic score indexing a DRD2-related co-expression network is associated with striatal dopamine function E D’Ambrosio, G Pergola, AF Pardiñas, T Dahoun, M Veronese, ... Scientific reports 12 (1), 12610, 2022 | 7 | 2022 |
| Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA study K Griffiths, A Egerton, E Millgate, A Anton, GJ Barker, B Deakin, R Drake, ... Schizophrenia 8 (1), 60, 2022 | 5 | 2022 |
| Changes in immunoglobulin levels during clozapine treatment in schizophrenia K Griffiths, MR Mellado, R Chung, J Lally, G McQueen, KV Sendt, ... Brain, Behavior, and Immunity 115, 223-228, 2024 | 3 | 2024 |
| Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia K Griffiths, SE Smart, GJ Barker, B Deakin, SM Lawrie, S Lewis, ... Schizophrenia research 260, 152-159, 2023 | 1 | 2023 |
| Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study E Millgate, K Griffiths, A Egerton, E Kravariti, C Casetta, B Deakin, ... BMJ open 12 (11), e062570, 2022 | 1 | 2022 |
| Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivo L Sportelli, DP Eisenberg, R Passiatore, E D’Ambrosio, LA Antonucci, ... Nature Communications 15 (1), 3342, 2024 | | 2024 |
| Treatment trajectory in people with borderline personality disorder from diagnosis to 12 months post-diagnosis: Abstracts of the 36th ECNP Congress 2023 C Dukes, SS Rose, J Dwyer, EO Palmer, J Yeow, M Oyesanya, K Griffiths, ... Neuroscience Applied 2 (S2), 83, 2023 | | 2023 |
| Dopamine and schizophrenia from bench to bedside: Discovery of a striatal co-expression risk gene set that predicts in vivo measures of striatal function. L Sportelli, DP Eisenberg, R Passiatore, E D'Ambrosio, LA Antonucci, ... bioRxiv, 2023.09. 20.558594, 2023 | | 2023 |
| Antipsychotic prescribing trends in schizophrenia between 2011 and 2021: real-world data from a US electronic health record database K Griffiths, AD Martínez-Gutiérrez, ME Rentería, R Patel Neuroscience Applied 1 (S2), 269, 2022 | | 2022 |
| F11 Antipsychotic treatment patterns in patients with schizophrenia: A real-world data analysis of electronic health records R Patel, K Griffiths, A Martinez-Gutierrez, L Garcia-Marin, ME Rentería Journal of Managed Care & Specialty Pharmacy 28 (10-a Suppl), S52-S53, 2022 | | 2022 |
| 3.17 The Impact of Executive Functioning Deficit on Illness Severity in Patients With an ADHD Diagnosis: A Real-World Data Study EOC Palmer, G Guruswamy, M Valko, K Griffiths, R Patel, SH Kollins Journal of the American Academy of Child and Adolescent Psychiatry 61 (10), S233, 2022 | | 2022 |
| P509. Tensor-Based Decomposition Associates Striatal Gene Co-Expression With Increased Dopamine Signaling in Individuals at Genetic Risk for Schizophrenia L Sportelli, D Eisenberg, E D'Ambrosio, R Passiatore, A Bertolino, Q Chen, ... Biological Psychiatry 91 (9), S294, 2022 | | 2022 |
| Relationships between clinical, neurochemical and genetic features of antipsychotic response in schizophrenia K Griffiths King's College London, 2022 | | 2022 |
| M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA K Griffiths, J MacCabe, A Egerton Schizophrenia Bulletin 46 (Supplement_1), S217-S217, 2020 | | 2020 |
| A network analysis of borderline personality disorder symptoms: a real-world data (RWD), electronic health record (EHR) study EOC Palmer, S Kuah, S Umashankar, K Griffiths, R Patel | | |
